Evidence map›Paper›PMID 36258259›Full record

ArticleJournal of pharmaceutical policy and practice2022

Mental health outcomes and workplace quality of life among South African pharmacists during the COVID-19 pandemic: a cross-sectional study.

Sherishka Dhindayal, Marothi P Letsoalo, Tanuja N Gengiah

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Survey on the Mental Health of Dispensing Pharmacists in the Auvergne-Rhône-Alpes Region (France).International journal of environmental research and public health · 2023
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sherishka DhindayalCentre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa. Sherishka.Dhindayal@caprisa.org.ORCID http://orcid.org/0000-0002-7837-3216
Marothi P LetsoaloCentre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Tanuja N GengiahCentre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa.
Centre for the AIDS Programme of Research in South Africa · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe effect of the COVID-19 pandemic on the mental health of healthcare workers is gaining attention globally. This study assessed the quality-of-working life (QoWL) and prevalence of, and risk factors for anxiety, depression and stress among South African pharmacists.

methodsAn online survey, after stratification by province, was sent to 3435 (target = 2454) randomly selected pharmacists between 14 April to 18 May 2021. Sociodemographic data were collected and mental health was assessed using the 7-item Generalized Anxiety Disorder scale, the 9-item Patient Health Questionnaire, Perceived Stress Scale and a modified Work-Related Quality-of-Life tool. Prevalence of anxiety, depression, stress and QoWL was estimated. A multivariate logistic regression analysis identified factors associated with mental health outcomes.

resultsA total of 953/2454 pharmacists (38.8%) responded. Of these, 56.5% were 40 years or younger, 78.5% were female, 45.4% were White race and 44.5% were practicing in a community pharmacy setting. Pharmacists demonstrated symptoms of anxiety (n = 605, 66.1%), depression (n = 561, 62.9%), stress (n = 642, 73.8%) and low QoWL (n = 409, 51.3%). Significant risk factors (aOR; 95%CI) for anxiety, depression and stress were female gender (1.96;1.36-2.83,1.84;1.27-2.67,1.58;1.05-2.38, history of mental health conditions (2.50; 1.52-4.13, 3.68; 2.19-6.19, 3.34;1.85-6.03) and significant COVID-19 mitigation changes to pharmacy practice (2.70; 1.36-5.38, 4.23; 2.06-8.70, 3.14;1.44-6.82), respectively. Practice changes were also associated with a low QoWL (5.19; 2.40-11.8). Compared to their Black/African colleagues, Indian pharmacists were at higher risk for anxiety (1.82; 1.03-3.23) and stress symptoms (2.28; 1.21-4.32), while risk for depression was significant amongst White pharmacists (1.86; 1.05-3.32). Pharmacists living apart from family were at significant risk for anxiety (1.66; 1.15-2.41), depression (1.52; 1.06-2.18) and low QoWL (1.60; 1.10-2.34).

conclusionsCOVID-19 pandemic has had a significant negative impact on the mental health of South African pharmacists. Interventions to support the psychological well-being and improve QoWL of pharmacists are needed.

Indexed as

COVID-19Mental healthPharmacistsQuality-of-working lifeSouth Africa

Identifiers

PMID36258259
PMCPMC9578222
OpenAlexW4306673744

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.